Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (112)

Advertisement

Research Article Free access | 10.1172/JCI105799

Stages in the incorporation of fatty acids into red blood cells

Stephen B. Shohet, David G. Nathan, and Manfred L. Karnovsky

Department of Medicine, Department of Harvard Medical School, Boston, Massachusetts 02215

Department of Biological Chemistry, Department of Harvard Medical School, Boston, Massachusetts 02215

Peter Bent Brigham Hospital, and Children's Hospital Medical Center, Boston, Massachusetts 02215

Find articles by Shohet, S. in: JCI | PubMed | Google Scholar

Department of Medicine, Department of Harvard Medical School, Boston, Massachusetts 02215

Department of Biological Chemistry, Department of Harvard Medical School, Boston, Massachusetts 02215

Peter Bent Brigham Hospital, and Children's Hospital Medical Center, Boston, Massachusetts 02215

Find articles by Nathan, D. in: JCI | PubMed | Google Scholar

Department of Medicine, Department of Harvard Medical School, Boston, Massachusetts 02215

Department of Biological Chemistry, Department of Harvard Medical School, Boston, Massachusetts 02215

Peter Bent Brigham Hospital, and Children's Hospital Medical Center, Boston, Massachusetts 02215

Find articles by Karnovsky, M. in: JCI | PubMed | Google Scholar

Published May 1, 1968 - More info

Published in Volume 47, Issue 5 on May 1, 1968
J Clin Invest. 1968;47(5):1096–1108. https://doi.org/10.1172/JCI105799.
© 1968 The American Society for Clinical Investigation
Published May 1, 1968 - Version history
View PDF
Abstract

Mature human erythrocytes were incubated with 14C-labeled palmitic acid bound to crystalline human albumin. Energy-dependent incorporation of the labeled palmitic acid into cell membrane phospholipids occurred, and various stages in this incorporation were defined.

Initially the palmitic acid was rapidy transferred from the albumin to a “superficial” membrane pool of free fatty acid (F-1), which was removable when the cells were washed with defatted albumin. This process was independent of red cell metabolism.

The labeled fatty acid then passed into a second “deeper” membrane pool of free fatty acids (F-2), which was not extractable with albumin. This process was energy-dependent and proceeded at a slower rate than the initial transfer from albumin to F-1.

Ultimately the labeled fatty acid was incorporated into phosphatides (PL). This process also was dependent upon cellular metabolism.

The kinetics of pulse label studies suggest that the processes observed were sequential and that precursor-product relationships exist between the F-1 and F-2 pools and the F-2 and PL pools. [Formula: see text] From the size and specific activities of these pools, calculations of the extent of phospholipid turnover were made. An approximate figure of 2% /hr or 30 nmoles/ml of packed red blood cells per hr was obtained. The figure was further calculated to represent an energy cost to the red blood cell of approximately 5% of the energy available from glycolysis.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1096
page 1096
icon of scanned page 1097
page 1097
icon of scanned page 1098
page 1098
icon of scanned page 1099
page 1099
icon of scanned page 1100
page 1100
icon of scanned page 1101
page 1101
icon of scanned page 1102
page 1102
icon of scanned page 1103
page 1103
icon of scanned page 1104
page 1104
icon of scanned page 1105
page 1105
icon of scanned page 1106
page 1106
icon of scanned page 1107
page 1107
icon of scanned page 1108
page 1108
Version history
  • Version 1 (May 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (112)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts